Clinical Trial Update: Pegylated Interferon to Treat Chronic Hepatitis D [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of pegylated interferon for chronic hepatitis D has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis D

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Hepatitis D | Phase 2 | Status: COMPLETED | Results posted: 2013-07-10